MitoRx Therapeutics: Funding, Investors & Team (Sep 2026)
MitoRx Therapeutics is a biotech firm working on innovative treatments that can effectively counteract the malfunctioning of mitochondria.
MitoRx Therapeutics has raised $5.0M across 2 funding rounds on record, the most recent a Seed of $5.0M announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MitoRx Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2023.
MitoRx Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
MitoRx Therapeutics announced a Seed in Apr 2022; the amount was not disclosed.
1.7 years later, a Seed of $5.0M was announced in Dec 2023.
MitoRx Therapeutics Founders and Leadership Team
Contact details for the MitoRx Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →MitoRx Therapeutics Funding Compared to Other Biotechnology Startups
MitoRx Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MitoRx Therapeutics in Biotechnology and Harwell
Companies Similar to MitoRx Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
MitoRx Therapeutics Funding FAQs
What does MitoRx Therapeutics do?
MitoRx Therapeutics is a biotech firm working on innovative treatments that can effectively counteract the malfunctioning of mitochondria.
How much funding has MitoRx Therapeutics raised?
MitoRx Therapeutics has raised $5.0M across 2 rounds on record. The most recent is a Seed of $5.0M announced in Dec 2023.
When did MitoRx Therapeutics last raise funding?
MitoRx Therapeutics' most recent funding round on record is a Seed of $5.0M, announced in Dec 2023.
Who founded MitoRx Therapeutics?
FundedIQ lists Norman Law (Founder) at MitoRx Therapeutics.
Where is MitoRx Therapeutics headquartered?
MitoRx Therapeutics is based in Harwell, Oxfordshire, United Kingdom.
How many employees does MitoRx Therapeutics have?
MitoRx Therapeutics is in the 11-50 employee band.
How does MitoRx Therapeutics' funding compare to other Biotechnology startups?
MitoRx Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MitoRx Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MitoRx Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.